FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2060778844> ?p ?o ?g. }

• W2060778844 endingPage "22" @default.
• W2060778844 startingPage "16" @default.
• W2060778844 abstract "Obesity is an increasing health problem that is reported to influence chemotherapy dosing. The extent to which this occurs and whether this affects outcomes in ovarian cancer was unclear. To describe chemotherapy dosing practices in normal, overweight and obese patients treated for FIGO Stage III/IV serous ovarian cancer in the Australian Ovarian Cancer Study (AOCS). To evaluate the relationship between body mass index (BMI), dose intensity of chemotherapy received, overall survival (OS) and progression free survival (PFS).Patient characteristics including age, height, weight, FIGO stage, serum creatinine, primary chemotherapy received and outcome data were extracted from medical records and entered into the AOCS database. Outcomes were analysed against BMI and relative dose intensity (RDI) received, based on calculations derived from a standard regimen (carboplatin AUC 5 and paclitaxel 175mg/m(2)).333 women were included in the analysis. 27% were overweight and 21% were obese. In cycle 1 66% of obese patients received carboplatin doses more than 5% below their optimal calculated dose, and 32% received sub-optimal paclitaxel doses, compared to 25% and 13% of normal weight patients respectively. Obese women were more likely to have received <85% RDI for carboplatin compared to normal weight women (p<0.001). BMI group and RDI of carboplatin and paclitaxel were not predictors of OS. Women who received less than 85% RDI for carboplatin had a worse PFS (univariate analysis, median PFS 11 versus 15 months; p=0.04). There was no significant association between RDI and OS or PFS in multivariate analysis.Obesity is common in ovarian cancer patients, and commonly results in lower chemotherapy dosing than recommended. Analysis of chemotherapy dosing from this study suggests that reduced dose intensity of carboplatin, which was more common in obese women, may impact on PFS in patients with advanced serous ovarian cancer." @default.
• W2060778844 created "2016-06-24" @default.
• W2060778844 creator A5015618057 @default.
• W2060778844 creator A5023581552 @default.
• W2060778844 creator A5023643377 @default.
• W2060778844 creator A5042517986 @default.
• W2060778844 creator A5043893475 @default.
• W2060778844 creator A5057552010 @default.
• W2060778844 date "2014-04-01" @default.
• W2060778844 modified "2023-10-05" @default.
• W2060778844 title "Impact of obesity on chemotherapy dosing for women with advanced stage serous ovarian cancer in the Australian Ovarian Cancer Study (AOCS)" @default.
• W2060778844 cites W1500273665 @default.
• W2060778844 cites W1550111394 @default.
• W2060778844 cites W1804059878 @default.
• W2060778844 cites W1879725303 @default.
• W2060778844 cites W1967518527 @default.
• W2060778844 cites W1969069350 @default.
• W2060778844 cites W1976568734 @default.
• W2060778844 cites W1996568521 @default.
• W2060778844 cites W2004144597 @default.
• W2060778844 cites W2036067444 @default.
• W2060778844 cites W2036449853 @default.
• W2060778844 cites W2039785378 @default.
• W2060778844 cites W2055543087 @default.
• W2060778844 cites W2056460672 @default.
• W2060778844 cites W2063482488 @default.
• W2060778844 cites W2076158597 @default.
• W2060778844 cites W2080092303 @default.
• W2060778844 cites W2116996913 @default.
• W2060778844 cites W2131278861 @default.
• W2060778844 cites W2146168335 @default.
• W2060778844 cites W2148374907 @default.
• W2060778844 cites W2152474929 @default.
• W2060778844 cites W2166630111 @default.
• W2060778844 cites W2169862066 @default.
• W2060778844 doi "https://doi.org/10.1016/j.ygyno.2014.01.030" @default.
• W2060778844 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24680586" @default.
• W2060778844 hasPublicationYear "2014" @default.
• W2060778844 type Work @default.
• W2060778844 sameAs 2060778844 @default.
• W2060778844 citedByCount "45" @default.
• W2060778844 countsByYear W20607788442014 @default.
• W2060778844 countsByYear W20607788442015 @default.
• W2060778844 countsByYear W20607788442016 @default.
• W2060778844 countsByYear W20607788442017 @default.
• W2060778844 countsByYear W20607788442018 @default.
• W2060778844 countsByYear W20607788442019 @default.
• W2060778844 countsByYear W20607788442020 @default.
• W2060778844 countsByYear W20607788442021 @default.
• W2060778844 countsByYear W20607788442023 @default.
• W2060778844 crossrefType "journal-article" @default.
• W2060778844 hasAuthorship W2060778844A5015618057 @default.
• W2060778844 hasAuthorship W2060778844A5023581552 @default.
• W2060778844 hasAuthorship W2060778844A5023643377 @default.
• W2060778844 hasAuthorship W2060778844A5042517986 @default.
• W2060778844 hasAuthorship W2060778844A5043893475 @default.
• W2060778844 hasAuthorship W2060778844A5057552010 @default.
• W2060778844 hasConcept C121608353 @default.
• W2060778844 hasConcept C126322002 @default.
• W2060778844 hasConcept C143998085 @default.
• W2060778844 hasConcept C146357865 @default.
• W2060778844 hasConcept C151730666 @default.
• W2060778844 hasConcept C2776694085 @default.
• W2060778844 hasConcept C2778239845 @default.
• W2060778844 hasConcept C2780221984 @default.
• W2060778844 hasConcept C2780427987 @default.
• W2060778844 hasConcept C2780586474 @default.
• W2060778844 hasConcept C2781451048 @default.
• W2060778844 hasConcept C29456083 @default.
• W2060778844 hasConcept C71924100 @default.
• W2060778844 hasConcept C86803240 @default.
• W2060778844 hasConceptScore W2060778844C121608353 @default.
• W2060778844 hasConceptScore W2060778844C126322002 @default.
• W2060778844 hasConceptScore W2060778844C143998085 @default.
• W2060778844 hasConceptScore W2060778844C146357865 @default.
• W2060778844 hasConceptScore W2060778844C151730666 @default.
• W2060778844 hasConceptScore W2060778844C2776694085 @default.
• W2060778844 hasConceptScore W2060778844C2778239845 @default.
• W2060778844 hasConceptScore W2060778844C2780221984 @default.
• W2060778844 hasConceptScore W2060778844C2780427987 @default.
• W2060778844 hasConceptScore W2060778844C2780586474 @default.
• W2060778844 hasConceptScore W2060778844C2781451048 @default.
• W2060778844 hasConceptScore W2060778844C29456083 @default.
• W2060778844 hasConceptScore W2060778844C71924100 @default.
• W2060778844 hasConceptScore W2060778844C86803240 @default.
• W2060778844 hasIssue "1" @default.
• W2060778844 hasLocation W20607788441 @default.
• W2060778844 hasLocation W20607788442 @default.
• W2060778844 hasOpenAccess W2060778844 @default.
• W2060778844 hasPrimaryLocation W20607788441 @default.
• W2060778844 hasRelatedWork W1565683009 @default.
• W2060778844 hasRelatedWork W1967715255 @default.
• W2060778844 hasRelatedWork W2053778437 @default.
• W2060778844 hasRelatedWork W2123388967 @default.
• W2060778844 hasRelatedWork W2150628057 @default.
• W2060778844 hasRelatedWork W2311734504 @default.
• W2060778844 hasRelatedWork W2320097775 @default.
• W2060778844 hasRelatedWork W2407788778 @default.

• next